PatternsRadar
Sign in

TARSONSTarsons Products Limited

NSE
303.40INR-0.30 (-0.10%)Close · 20 Nov 2026
12 Nov 2026Last results
HealthcareSector
Healthcare Equipment & SuppliesIndustry
₹1,614 CrMarket cap
217.3P/E (TTM)
16.6%Delivery

Filings & corporate actions

20 results filed
CSV
Next results · Q3 FY27
Expected 6 Feb 2027 – 14 Feb 2027
Estimate: filed 37–45 days after quarter end, last 5 times
Dividend
₹2.00 per share · last 20 Sept 2024
2026
  • 12 NovresultsResults · Q2 FY27 · consolidated and standalone+1.2%NSE
  • 9 OctshareholdingShareholding · 30 Sept 2026-2.0%NSE
  • 10 AugresultsResults · Q1 FY27 · consolidated and standalone-5.2%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026-2.1%NSE
  • 23 MayresultsResults · Q4 FY26 · consolidated-1.8%NSE
  • 22 MayresultsResults · Q4 FY26 · consolidated and standalone-1.8%NSE
  • 9 AprshareholdingShareholding · 31 Mar 2026-2.1%NSE
  • 6 FebresultsResults · Q3 FY26 · consolidated and standalone-2.5%NSE
  • 8 JanshareholdingShareholding · 31 Dec 2025-1.5%NSE

Reaction to results · all yearsrose on day 0 in 4 of 20 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2712 Nov 2026+1.2%-2.6%—1.1×
Q1 FY2710 Aug 2026-5.2%+7.4%+3.7%1.0×
Q4 FY2622 May 2026-1.8%-5.1%+20.3%17.1×
Q3 FY266 Feb 2026-2.5%-9.6%-11.3%1.0×
Q2 FY2612 Nov 2025-6.9%-14.7%-11.5%4.7×
Q1 FY2612 Aug 2025-4.2%-8.8%-13.0%1.1×
Q4 FY2529 May 2025-2.9%-3.9%-3.2%1.3×
Q3 FY2514 Feb 2025-2.2%-6.2%-5.4%1.0×
Q2 FY258 Nov 2024-3.3%-9.9%-1.5%0.7×
Q1 FY2514 Aug 2024-5.9%+2.2%-1.7%2.7×
Q4 FY2431 May 2024-3.1%-1.4%+19.1%1.1×
Q3 FY2413 Feb 2024-0.4%+2.1%-15.6%0.7×
Q2 FY2411 Nov 2023+1.2%-1.7%-3.3%0.2×
Q1 FY2411 Aug 2023-4.7%-12.0%-10.1%4.1×
Q4 FY2328 May 2023+0.2%+0.3%+3.7%1.4×
Q3 FY2312 Feb 2023-8.9%-13.6%-20.2%5.3×
Q2 FY235 Nov 2022-7.6%-10.6%-5.5%5.1×
Q1 FY236 Aug 2022-9.7%-10.5%-1.5%5.8×
Q4 FY2227 May 2022+4.1%+0.5%+0.8%1.6×
Q3 FY227 Feb 2022-5.5%-7.2%-10.3%1.4×
Average-3.4%-5.3%-3.5%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+20.8%
Profit YoY-110.4%
Interest cost YoY+22.9%
Revenue QoQ+12.2%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue+14.7%—————
Profit-53.6%—————

Key data

Open309.80
Day range298.00 – 314.30
52-week range164.45 – 375.00
From 52w high-19.1%
RSI (14)44.7
ATR (14)14.86
Volume1.01L
Avg volume (20D)65.3K
Rel volume1.54×
Volatility (1Y)52.4%
Turnover₹3.1Cr
Traded value (NSE)₹3.1Cr
VWAP307.25
SMA 50 / 200317.15 / 262.91
Price band20%

Delivery percentage

Latest · 20 Nov 202616.6%
20-day avg50.4%
1-year avg47.1%
Percentile (own history)1st
Range4.0–97.6%
Sessions1,234

Over the last 20 sessions TARSONS settled 50.4% of its traded quantity, which is above average for an NSE equity. Its one-year average is 47.1%, so recent sessions are running 3.2 points higher than usual. The latest session ranks higher than 1% of the 1,234 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders80.9K · -3.1% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy98 days ago
IndustryMedical Equipment & Supplies

Performance returns

1D1W1M3M6M1Y
Price-0.10%-3.82%-1.70%-10.05%+43.77%+26.57%

Valuation

Market cap₹1,614 Cr
Market cap (NSE)₹1,614 Cr
Free-float cap₹851 Cr
P/E (TTM)217.3
P/E (NSE)217.5
EPS (TTM)1.40
P/B2.5
Net margin (TTM)1.6%
Other income / PBT201.6%
ROE1.2%
Debt / equity0.61
Shares outstanding5.32Cr
Listed26 Nov 2021

Ownership

Promoter47.30%
Promoter Δ QoQ0.00 pp
Public52.70%
FII0.55%
DII0.61%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)107.9120.9110.2123.7
YoY chg+12.8%+7.3%+20.7%+20.8%
Net profit (₹ Cr)5.04.2(1.4)(0.3)
YoY chg-4.2%-59.0%-181.0%-110.4%
Net margin4.7%3.5%-1.3%-0.3%
EPS0.950.79-0.27-0.06

Shareholding over time

By quarter

30 Sept 2026 · promoter 47.30% · public 52.70%
25 Nov 2021: promoter 47.30%31 Dec 2021: promoter 47.30%31 Mar 2022: promoter 47.31%30 Jun 2022: promoter 47.31%30 Sept 2022: promoter 47.31%31 Dec 2022: promoter 47.31%31 Mar 2023: promoter 47.31%30 Jun 2023: promoter 47.31%30 Sept 2023: promoter 47.31%31 Dec 2023: promoter 47.31%31 Mar 2024: promoter 47.31%30 Jun 2024: promoter 47.31%30 Sept 2024: promoter 47.31%31 Dec 2024: promoter 47.31%31 Mar 2025: promoter 47.31%30 Jun 2025: promoter 47.31%30 Sept 2025: promoter 47.31%31 Dec 2025: promoter 47.30%31 Mar 2026: promoter 47.30%30 Jun 2026: promoter 47.30%30 Sept 2026: promoter 47.30%
2021-112026-09
  • Promoter
  • Public and others
Promoter
47.30%
Public
52.70%
Promoter change
0.00 pp
Filed
9 Oct 2026
FII
0.55%
DII
0.61%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.55%

+0.40 pp QoQ

Retail ≤ ₹2L
16.29%

-0.61 pp QoQ

HNI > ₹2L
5.25%

-0.43 pp QoQ

NRI
0.80%

+0.02 pp QoQ

Bodies corporate
5.10%

+0.09 pp QoQ

Shareholders
80,867

-3.1% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
SANJIVE SEHGALPromoter · Individual26.98%
CLEAR VISION INVESTMENT HOLDINGS PTE LIMITEDCorporate23.42%
ARYAN SEHGALPromoter · Individual20.30%
GRACIOUS ADVISORS LLPCorporate3.15%
JYOTI LIKHARIPromoter · Individual0.01%
ANU NAGRATHPromoter · Individual0.01%
ANSHU KAPURPromoter · Individual0.01%
NEETA ARORAPromoter · Individual0.01%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 20 Sept 2024 CSV
Financial yearPaymentsDeclaredAdjusted
FY2024-251₹2.00₹2.00
Ex-dateRecord dateDeclaredAdjusted
20 Sept 2024—₹2.00₹2.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Bulk & block deals · 14 Aug 2026

CSV
12 of 69 deals
By year
DateDealClientQuantityPriceValue
14 Aug 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED3.74L351.18₹13.1Cr
14 Aug 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED3.74L350.87₹13.1Cr
14 Aug 2026Sell · bulkJUNOMONETA FINSOL PRIVATE LIMITED3.28L351.12₹11.5Cr
14 Aug 2026Buy · bulkJUNOMONETA FINSOL PRIVATE LIMITED3.26L350.74₹11.4Cr
14 Aug 2026Sell · bulkMICROCURVES TRADING PRIVATE LIMITED2.85L357.03₹10.2Cr
14 Aug 2026Buy · bulkMICROCURVES TRADING PRIVATE LIMITED2.85L356.75₹10.1Cr
21 Jul 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED3.50L318.86₹11.2Cr
21 Jul 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED3.50L318.63₹11.2Cr
6 Jul 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED3.84L300.42₹11.5Cr
6 Jul 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED3.84L300.25₹11.5Cr
6 Jul 2026Buy · bulkMICROCURVES TRADING PRIVATE LIMITED3.02L302.94₹9.2Cr
6 Jul 2026Sell · bulkMICROCURVES TRADING PRIVATE LIMITED3.02L302.81₹9.2Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Open positions in NSE’s securities lending and borrowing market: shares borrowed and not yet returned, the usual way to hold a short beyond the day.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 13 Apr 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations61.8105.784.899.295.7112.791.4102.3107.9120.9110.2123.7
Other income3.23.42.98.40.83.83.35.88.46.66.04.4
Total income65.0109.187.7107.796.5116.594.7108.1116.3127.5116.2128.1
Total expenses51.592.181.492.888.5100.991.7102.5107.5122.0117.5127.4
└ Finance costs2.54.34.34.85.05.25.15.26.06.36.36.6
└ Depreciation10.112.311.014.017.420.019.922.525.029.127.028.3
Profit before tax13.617.06.314.98.015.63.05.67.55.8(1.3)0.7
Tax expense3.66.72.34.62.85.41.22.32.51.60.11.0
Net profit9.910.34.010.35.310.21.83.35.04.2(1.4)(0.3)
EPS1.871.940.751.930.991.920.340.620.950.79-0.27-0.06
Net margin16.06%9.76%4.74%10.37%5.50%9.05%1.95%3.25%4.67%3.46%-1.31%-0.28%
PBT margin21.93%16.12%7.45%14.98%8.41%13.82%3.32%5.46%6.96%4.77%-1.20%0.54%
Tax rate26.75%39.47%36.42%30.77%34.65%34.47%41.19%40.58%32.92%27.53%—151.57%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 12 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets972.21,054.31,080.01,163.71,185.81,179.5
Current assets235.3262.7242.6254.1265.8274.3
└ Cash & equivalents17.120.025.125.923.215.7
└ Other bank balances5.516.40.55.42.110.9
└ Current investments0.00.00.00.00.00.0
└ Trade receivables77.969.979.672.585.489.5
└ Inventories128.7139.4126.0135.4129.8134.0
Total equity612.9613.9630.2626.6634.7633.1
└ Attributable to owners612.9613.9630.2626.6634.7633.1
└ Non-controlling interest—0.00.00.0—0.0
└ Share capital10.610.610.610.610.610.6
Borrowings256.8304.9328.6385.0382.6387.3
└ Current154.8144.9123.7170.4173.1198.5
└ Non-current102.0160.0204.9214.6209.5188.9
Trade payables14.616.115.714.120.322.3
Current liabilities213.2220.0175.7247.8264.2251.8
Total liabilities359.3440.4449.8537.1551.1546.4
Net debt234.2268.5302.9353.7357.4360.7
Debt / equity0.420.500.520.610.600.61
Current ratio1.101.191.381.031.011.09

Cash flow, year to date

 FY22FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow83.5102.722.0114.244.5118.553.8
└ Capex(132.0)(184.3)(58.9)(151.7)(71.2)(125.6)(47.5)
Free cash flow(48.5)(81.6)(37.0)(37.5)(26.8)(7.1)6.3
Investing cash flow(137.9)(285.0)(57.7)(145.5)(78.3)(130.4)(50.8)
Financing cash flow129.6135.638.638.932.18.9(9.9)
└ Dividends paid0.00.00.0(10.6)0.00.00.0
└ Buybacks0.00.00.00.00.00.00.0
Net change in cash75.1(46.7)2.98.0(1.7)(3.0)(6.9)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

TARSONS at a glance

  • TARSONS closed at ₹303.4 on 20 Nov 2026, -0.10% on the day, +26.6% over one year, 19.1% below its 52-week high of ₹375.
  • Delivery was 16.6% of traded quantity on 20 Nov 2026, the 1st percentile of its own 1,234 sessions with a reading (20-session average 50.4%, 1-year average 47.1%).
  • Market capitalisation is ₹1,614 crore at a trailing P/E of 217.3 (trailing EPS ₹1.4).
  • Q2 FY27 results (consolidated, filed 12 Nov 2026): revenue ₹124 crore (+20.8% year on year), net profit ₹-0 crore (-110.4%); the price moved +1.2% on the first session after.
  • Promoters held 47.30% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 6 Feb 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryMedical Equipment & Supplies
ISININE144Z01023
SeriesEQ
Listed26 Nov 2021
IPO price662.00 · band Rs.635 to Rs.662
IPO listing26 Nov 2021
NSE market cap · 17 Nov 2026₹1,648 Cr
Free-float market cap (NSE)₹483 Cr
Shares outstanding (NSE)5.32Cr
History from26 Nov 2021
Sessions1,237

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.